Ian H. Kratter, Ph.D.
Affiliations: | 2013 | Biomedical Sciences | University of California, San Francisco, San Francisco, CA |
Area:
Molecular Mechanisms of Synaptic Plasticity and NeurodegenerationGoogle:
"Ian Kratter"Mean distance: 24.58 (cluster 31)
Parents
Sign in to add mentor| Steven Finkbeiner | grad student | 2013 | UCSF | |
| (Serine 421 is a Crucial Mediator of Pathology in a Mouse Model of Huntington's Disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kratter IH, Zahed H, Lau A, et al. (2016) Serine 421 regulates mutant huntingtin toxicity and clearance in mice. The Journal of Clinical Investigation |
| Lee JM, Kim KH, Shin A, et al. (2015) Sequence-Level Analysis of the Major European Huntington Disease Haplotype. American Journal of Human Genetics. 97: 435-44 |
| Vashishtha M, Ng CW, Yildirim F, et al. (2013) Targeting H3K4 trimethylation in Huntington disease. Proceedings of the National Academy of Sciences of the United States of America. 110: E3027-36 |
| Kratter IH, Finkbeiner S. (2010) PolyQ disease: too many Qs, too much function? Neuron. 67: 897-9 |